SELISHIA MCFARLANE: Open Payments
NPI 1558774711 · CONYERS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$350 in 15 payments from 9 companies in 2025. Trend: 2023 $407 · 2024 $194 · 2025 $350
Food & beverage: $350
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 6 | $153 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $42 |
| Regeneron Healthcare Solutions, Inc. | 1 | $29 |
| VIVUS LLC | 1 | $29 |
| Janssen Biotech, Inc. | 1 | $24 |
| Aimmune Therapeutics, Inc. | 1 | $21 |
| GENZYME CORPORATION | 1 | $21 |
| Madrigal Pharmaceuticals | 1 | $19 |
| Phathom Pharmaceuticals, Inc. | 1 | $12 |
Products named: LINZESS, DUPIXENT, XIFAXAN, MAVYRET, PANCREAZE, RINVOQ, TREMFYA, ZENPEP.
Industry payments across GA — which companies pay providers there.
